about
Antibiotic inducibility of the MexXY multidrug efflux system of Pseudomonas aeruginosa: involvement of the antibiotic-inducible PA5471 gene productTechniques for Screening Translation InhibitorsThe Lantibiotic NAI-107 Binds to Bactoprenol-bound Cell Wall Precursors and Impairs Membrane FunctionsHuman commensals producing a novel antibiotic impair pathogen colonizationPreclinical evaluation of novel antibacterial agents by microbiological and molecular techniquesPrediction of the mechanism of action of fusaricidin on Bacillus subtilisRole of lon, an ATP-dependent protease homolog, in resistance of Pseudomonas aeruginosa to ciprofloxacinComprehensive analysis of temporal alterations in cellular proteome of Bacillus subtilis under curcumin treatmentDaptomycin versus Friulimicin B: in-depth profiling of Bacillus subtilis cell envelope stress responsesMass spectrometry-based proteomics and its application to studies of Porphyromonas gingivalis invasion and pathogenicity.Antimicrobial peptide cWFW kills by combining lipid phase separation with autolysis.Identification of antimicrobial targets using a comprehensive genomic approach.The development of ciprofloxacin resistance in Pseudomonas aeruginosa involves multiple response stages and multiple proteins.Staphylococcus aureus NfrA (SA0367) is a flavin mononucleotide-dependent NADPH oxidase involved in oxidative stress response.Demonstration of biological activities of extracts from Isodon rugosus Wall. Ex Benth: Separation and identification of bioactive phytoconstituents by GC-MS analysis in the ethyl acetate extract.Postgenomic strategies in antibacterial drug discovery.Challenges of antibacterial discoveryDiscovering the mechanism of action of novel antibacterial agents through transcriptional profiling of conditional mutants.Proteomic response of Bacillus subtilis to lantibiotics reflects differences in interaction with the cytoplasmic membrane.Dysregulation of bacterial proteolytic machinery by a new class of antibiotics.The antibiotic ADEP reprogrammes ClpP, switching it from a regulated to an uncontrolled protease.Regulation of LiaRS-dependent gene expression in bacillus subtilis: identification of inhibitor proteins, regulator binding sites, and target genes of a conserved cell envelope stress-sensing two-component system.Fluctuation of multiple metabolic pathways is required for Escherichia coli in response to chlortetracycline stress.In Vitro Antimicrobial, Antioxidant Activities and Phytochemical Analysis of Canarium patentinervium Miq. from Malaysia.New class of bacterial phenylalanyl-tRNA synthetase inhibitors with high potency and broad-spectrum activity.Antibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens.Towards a comprehensive understanding of Bacillus subtilis cell physiology by physiological proteomics.Characterization and prediction of the mechanism of action of antibiotics through NMR metabolomics.The Pleiotropic Antibacterial Mechanisms of Ursolic Acid against Methicillin-Resistant Staphylococcus aureus (MRSA).From genomics via proteomics to cellular physiology of the Gram-positive model organism Bacillus subtilis.Exploring simvastatin, an antihyperlipidemic drug, as a potential topical antibacterial agentTranscriptional profiling reveals that daptomycin induces the Staphylococcus aureus cell wall stress stimulon and genes responsive to membrane depolarization.Prediction of mechanisms of action of antibacterial compounds by gene expression profiling.Phytochemical Screening and Antimicrobial Activity of Some Medicinal Plants Against Multi-drug Resistant Bacteria from Clinical Isolates.Proteomic signatures uncover thiol-specific electrophile resistance mechanisms in Bacillus subtilis.Daptomycin inhibits cell envelope synthesis by interfering with fluid membrane microdomains.Comparative genome analysis of ciprofloxacin-resistant Pseudomonas aeruginosa reveals genes within newly identified high variability regions associated with drug resistance development.Peptide deformylase--a promising therapeutic target for tuberculosis and antibacterial drug discovery.Small cationic antimicrobial peptides delocalize peripheral membrane proteins.Using genomics to develop novel antibacterial therapeutics.
P2860
Q24542408-500F1CAB-79B4-46B1-A5CE-0F084B3E26F5Q26746984-0358D0F6-FE11-49B5-BC4F-27CE43FC6465Q27682197-2D020C15-03AC-431A-B5A9-B5DA0897984AQ28005468-C1A40731-F001-4F55-A2C8-491C5043575AQ28273315-6DDE0E2D-81F4-49A6-A8B0-25562254BB7EQ28485285-EDEA83C7-3905-47DD-B7C4-64E10547C6ABQ28492686-D901C84E-DB82-49B9-8A6E-FB9BF84BD99BQ28546365-4CFCA620-15E1-41B8-8496-E0F6E23B4B86Q28754911-3292BBFB-3D1C-4239-AE90-C52C93CC887CQ30439892-6E4D873A-7711-490C-9BB6-1646004AE535Q30841307-D7CE471A-C10A-4E5A-BC79-F8A6C329D075Q31033436-9EA3A921-0DE5-452A-814E-9F70BCC49EFCQ33653162-A377162F-B342-4765-BC93-C0D1E5E1B534Q33716670-1E0726E5-EBB3-4FD4-88D3-B88104575FF7Q33743496-F40603EF-1516-4461-8AF0-EF3FC7DDD464Q33745572-E7EA4C20-BCB8-43AA-B5BF-2F2629691E39Q33793074-DFA872BB-4213-4A5D-B60B-C6813528D189Q33803840-A16EF0D8-7693-48AF-B990-9E0F824AFFFFQ34394918-A0A36664-B989-4410-AA00-2EAC85F39586Q34456129-DDCF3B95-379D-427C-8F4B-D4F6D81B27DBQ34615400-4F45AC29-0E71-4597-9308-F948C5FC450BQ34976478-57CD9345-52BD-4F00-9FBC-49E7FA9C8EF0Q35089475-E3752939-3F71-4905-B448-51A8E7EE2355Q35110325-329D1455-2E7B-4D03-8C66-C789B450AA6DQ35547361-2F0B6F7D-AB8C-4575-BB09-B3B51258D6A7Q35943844-4961C4B8-6C80-49B0-8829-A27C7DF7DE86Q35946891-48B4CA87-0B61-4F08-81F5-926A18300CC6Q36012460-15204907-A5F7-434B-8AE0-10967AFFEA37Q36072640-633E6E86-A0E1-45D9-B9D6-BB5354FD5DEDQ36189297-46F0897D-6EEA-4202-8590-053EB56CC873Q36265781-E60397C1-14E1-49CF-A4FA-0BAA45E76886Q36482900-E2488233-250A-4761-AAB3-DB20811EFA9AQ36670294-A3AB9740-6592-4D39-8F53-047B0C4FBEA0Q36865292-C7461A66-EB38-470E-999C-9440938657B1Q37087384-12FF76DF-FBB8-49FB-AC5D-0B16996907C1Q37417749-B25D9C82-8D47-4C40-94FC-6D1B6E4C1EF2Q37469236-C0AB89DF-C3C5-4F79-A6AB-E77EF6DDD87CQ37521070-4E96A5F0-7465-4A89-8710-3BF9EA87B1D0Q37702026-FCD47771-BAED-402C-B91C-FF97C721E784Q37776507-8E66265F-A4FC-486D-9685-9315FD5EAA5F
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Proteomic approach to understanding antibiotic action
@en
Proteomic approach to understanding antibiotic action.
@nl
type
label
Proteomic approach to understanding antibiotic action
@en
Proteomic approach to understanding antibiotic action.
@nl
prefLabel
Proteomic approach to understanding antibiotic action
@en
Proteomic approach to understanding antibiotic action.
@nl
P2093
P2860
P1476
Proteomic approach to understanding antibiotic action
@en
P2093
Harald Labischinski
Heike Brötz
Michael Hecker
P2860
P304
P356
10.1128/AAC.47.3.948-955.2003
P407
P577
2003-03-01T00:00:00Z